Sarcoid‐like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab

Immune checkpoint inhibitors (ICIs) have become the standard of care for the treatment of non‐small cell lung cancer (NSCLC). With the increasing use of ICIs, clinicians should be familiar with their immune‐related adverse events, including sarcoid‐like reactions, which have been associated with the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Thorac Cancer
Egile Nagusiak: Takamori, Shinkichi, Furubayashi, Nobuki, Taguchi, Kenichi, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Yamaguchi, Masafumi, Toyozawa, Ryo, Seto, Takashi, Negishi, Takahito, Nakamura, Motonobu, Okamoto, Tatsuro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons Australia, Ltd 2021
Gaiak:
Case Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287006/
https://ncbi.nlm.nih.gov/pubmed/34002950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.14011
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak